Badgley Phelps Wealth Managers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Badgley Phelps Wealth Managers's PFE Position: Q1 2026 in Review
Badgley Phelps Wealth Managers reduced its Pfizer (PFE) stake by 1.1% in Q1 2026, selling an estimated $17K and leaving 57,172 shares worth $1.61M. The position accounts for 0.03% of the portfolio, ranked #176.
Badgley Phelps Wealth Managers first reported a position in PFE in Q3 2021 and has held it in 19 quarters since. The position peaked at $20M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Badgley Phelps Wealth Managers held 57,172 shares of Pfizer worth $1.61M as of Q1 2026.
- Badgley Phelps Wealth Managers sold 637 Pfizer shares in Q1 2026, an estimated $17K.
- Pfizer made up 0.03% of Badgley Phelps Wealth Managers's portfolio in Q1 2026, its #176 holding.
- Badgley Phelps Wealth Managers first reported a position in Pfizer in Q3 2021 and has held it in 19 quarters since.
- Badgley Phelps Wealth Managers's Pfizer position peaked at $20M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Badgley Phelps Wealth Managers's 13F filing for Q1 2026, filed 15 Apr 2026.